{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:40:39Z","timestamp":1792788039510,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Key R&D Program of China","award":["2023YFC2507002 to Y.L. and Y.S., 2023YFC3402704 to Y.S."],"award-info":[{"award-number":["2023YFC2507002 to Y.L. and Y.S., 2023YFC3402704 to Y.S."]}]},{"name":"the National High Level Hospital Clinical Research Funding","award":["2022CR72 to X.L."],"award-info":[{"award-number":["2022CR72 to X.L."]}]},{"name":"the National Natural Science Foundation of China","award":["82341030 and 82173061 to W.C., 82273350 to X.L., U23A20460 to X.L. and Y.L., 82103426 to Y.L."],"award-info":[{"award-number":["82341030 and 82173061 to W.C., 82273350 to X.L., U23A20460 to X.L. and Y.L., 82103426 to Y.L."]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08628-7","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:43:17Z","timestamp":1783939397000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An integrative epigenomic and single-cell framework identifies a prognostic DNA methylation risk score and ZNF638 silencing in urothelial carcinoma"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0748-7179","authenticated-orcid":false,"given":"Bin","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunru","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaojie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengwei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Papaleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4111-5360","authenticated-orcid":false,"given":"Weimin","family":"Ci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"8628_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2025.02.023","author":"A Masson-Lecomte","year":"2025","unstructured":"Masson-Lecomte A, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: Summary of the 2025 Update. Eur Urol. 2025. https:\/\/doi.org\/10.1016\/j.eururo.2025.02.023.","journal-title":"Eur Urol"},{"key":"8628_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10\u201345. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA Cancer J Clin"},{"key":"8628_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2025.04.008","author":"CE Chu","year":"2025","unstructured":"Chu CE, et al. Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma. Eur Urol. 2025. https:\/\/doi.org\/10.1016\/j.eururo.2025.04.008.","journal-title":"Eur Urol"},{"key":"8628_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.urolonc.2018.11.015","volume":"40","author":"JB da Costa","year":"2022","unstructured":"da Costa JB, et al. Molecular tumor heterogeneity in muscle invasive bladder cancer: Biomarkers, subtypes, and implications for therapy. Urol Oncol. 2022;40:287\u201394. https:\/\/doi.org\/10.1016\/j.urolonc.2018.11.015.","journal-title":"Urol Oncol"},{"key":"8628_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.eururo.2024.07.027","volume":"86","author":"P Gontero","year":"2024","unstructured":"Gontero P, et al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-A Summary of the 2024 Guidelines Update. Eur Urol. 2024;86:531\u201349. https:\/\/doi.org\/10.1016\/j.eururo.2024.07.027.","journal-title":"Eur Urol"},{"key":"8628_CR6","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/cncr.22084","volume":"107","author":"Y Lotan","year":"2006","unstructured":"Lotan Y, Svatek RS, Sagalowsky AI. Should we screen for bladder cancer in a high-risk population? A cost per life-year saved analysis. Cancer. 2006;107:982\u201390. https:\/\/doi.org\/10.1002\/cncr.22084.","journal-title":"Cancer"},{"key":"8628_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.eururo.2018.09.003","volume":"75","author":"JI Warrick","year":"2019","unstructured":"Warrick JI, et al. Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic Variants. Eur Urol. 2019;75:18\u201322. https:\/\/doi.org\/10.1016\/j.eururo.2018.09.003.","journal-title":"Eur Urol"},{"key":"8628_CR8","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1158\/1078-0432.CCR-18-2039","volume":"25","author":"F Audenet","year":"2019","unstructured":"Audenet F, et al. Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma. Clin Cancer Res. 2019;25:967\u201376. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-2039.","journal-title":"Clin Cancer Res"},{"key":"8628_CR9","doi-asserted-by":"publisher","first-page":"1298087","DOI":"10.3389\/fimmu.2024.1298087","volume":"15","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, et al. Investigating cellular similarities and differences between upper tract urothelial carcinoma and bladder urothelial carcinoma using single-cell sequencing. Front Immunol. 2024;15:1298087. https:\/\/doi.org\/10.3389\/fimmu.2024.1298087.","journal-title":"Front Immunol"},{"key":"8628_CR10","doi-asserted-by":"publisher","unstructured":"Fujii Y, et al. Molecular classification and diagnostics of upper urinary tract urothelial carcinoma. Cancer Cell.2021;39:793\u2013809-e798. https:\/\/doi.org\/10.1016\/j.ccell.2021.05.008.","DOI":"10.1016\/j.ccell.2021.05.008"},{"key":"8628_CR11","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.eururo.2017.05.032","volume":"72","author":"EJ Pietzak","year":"2017","unstructured":"Pietzak EJ, et al. Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets. Eur Urol. 2017;72:952\u20139. https:\/\/doi.org\/10.1016\/j.eururo.2017.05.032.","journal-title":"Eur Urol"},{"key":"8628_CR12","doi-asserted-by":"publisher","unstructured":"Robertson AG, et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell. 2017. 171:540\u2013556-e525. https:\/\/doi.org\/10.1016\/j.cell.2017.09.007.","DOI":"10.1016\/j.cell.2017.09.007"},{"key":"8628_CR13","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","volume":"25","author":"W Choi","year":"2014","unstructured":"Choi W, et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell. 2014;25:152\u201365. https:\/\/doi.org\/10.1016\/j.ccr.2014.01.009.","journal-title":"Cancer Cell"},{"key":"8628_CR14","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jmoldx.2022.05.006","volume":"24","author":"NA Marzouka","year":"2022","unstructured":"Marzouka NA, et al. The Lund Molecular Taxonomy Applied to Non-Muscle-Invasive Urothelial Carcinoma. J Mol Diagn. 2022;24:992\u20131008. https:\/\/doi.org\/10.1016\/j.jmoldx.2022.05.006.","journal-title":"J Mol Diagn"},{"key":"8628_CR15","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun A, et al. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol. 2020;77:420\u201333. https:\/\/doi.org\/10.1016\/j.eururo.2019.09.006.","journal-title":"Eur Urol"},{"key":"8628_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12916-021-02163-6","volume":"19","author":"J Hu","year":"2021","unstructured":"Hu J, et al. 5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer. BMC Med. 2021;19:289. https:\/\/doi.org\/10.1186\/s12916-021-02163-6.","journal-title":"BMC Med"},{"key":"8628_CR17","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/ijc.33794","volume":"149","author":"H Lai","year":"2021","unstructured":"Lai H, et al. Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer. Int J Cancer. 2021;149:2099\u2013115. https:\/\/doi.org\/10.1002\/ijc.33794.","journal-title":"Int J Cancer"},{"key":"8628_CR18","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1038\/s41467-020-18916-5","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen Z, et al. Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nat Commun. 2020;11:5077. https:\/\/doi.org\/10.1038\/s41467-020-18916-5.","journal-title":"Nat Commun"},{"key":"8628_CR19","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/s41417-024-00779-3","volume":"31","author":"S Xin","year":"2024","unstructured":"Xin S, et al. ScRNA-seq revealed the tumor microenvironment heterogeneity related to the occurrence and metastasis in upper urinary tract urothelial carcinoma. Cancer Gene Ther. 2024;31:1201\u201320. https:\/\/doi.org\/10.1038\/s41417-024-00779-3.","journal-title":"Cancer Gene Ther"},{"key":"8628_CR20","doi-asserted-by":"publisher","first-page":"7745","DOI":"10.7150\/thno.77281","volume":"12","author":"Y Liang","year":"2022","unstructured":"Liang Y, et al. Single-cell atlases link macrophages and CD8(+) T-cell subpopulations to disease progression and immunotherapy response in urothelial carcinoma. Theranostics. 2022;12:7745\u201359. https:\/\/doi.org\/10.7150\/thno.77281.","journal-title":"Theranostics"},{"key":"8628_CR21","doi-asserted-by":"publisher","first-page":"6649","DOI":"10.7150\/ijbs.114618","volume":"21","author":"S Xiong","year":"2025","unstructured":"Xiong S, et al. Single-cell and spatial transcriptomic analysis reveal cellular heterogeneity and cancer cell-intrinsic major histocompatibility complex II expression in urothelial carcinoma. Int J Biol Sci. 2025;21:6649\u201373. https:\/\/doi.org\/10.7150\/ijbs.114618.","journal-title":"Int J Biol Sci"},{"key":"8628_CR22","doi-asserted-by":"publisher","unstructured":"Su X, et al. Comprehensive integrative profiling of upper tract urothelial carcinomas. Genome Biol. 2021;22. https:\/\/doi.org\/10.1186\/s13059-020-02230-w.","DOI":"10.1186\/s13059-020-02230-w"},{"key":"8628_CR23","doi-asserted-by":"publisher","unstructured":"Li J, et al. DNA methylation subtypes guiding prognostic assessment and linking to responses the DNA methyltransferase inhibitor SGI-110 in urothelial carcinoma. BMC Med. 2022;20. https:\/\/doi.org\/10.1186\/s12916-022-02426-w.","DOI":"10.1186\/s12916-022-02426-w"},{"key":"8628_CR24","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1200\/JCO.2005.03.163","volume":"23","author":"JW Catto","year":"2005","unstructured":"Catto JW, et al. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. J Clin Oncol. 2005;23:2903\u201310. https:\/\/doi.org\/10.1200\/JCO.2005.03.163.","journal-title":"J Clin Oncol"},{"key":"8628_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrurol.2013.89","volume":"10","author":"R Kandimalla","year":"2013","unstructured":"Kandimalla R, van Tilborg AA, Zwarthoff EC. DNA methylation-based biomarkers in bladder cancer. Nat Rev Urol. 2013;10:327\u201335. https:\/\/doi.org\/10.1038\/nrurol.2013.89.","journal-title":"Nat Rev Urol"},{"key":"8628_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13059-020-02126-9","volume":"21","author":"AE Teschendorff","year":"2020","unstructured":"Teschendorff AE, Zhu T, Breeze CE, Beck S. EPISCORE: cell type deconvolution of bulk tissue DNA methylomes from single-cell RNA-Seq data. Genome Biol. 2020;21:221. https:\/\/doi.org\/10.1186\/s13059-020-02126-9.","journal-title":"Genome Biol"},{"key":"8628_CR27","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/ng.3805","volume":"49","author":"S Guo","year":"2017","unstructured":"Guo S, et al. Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA. Nat Genet. 2017;49:635\u201342. https:\/\/doi.org\/10.1038\/ng.3805.","journal-title":"Nat Genet"},{"key":"8628_CR28","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1101\/gr.175141.114","volume":"24","author":"I Scheinin","year":"2014","unstructured":"Scheinin I, et al. DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly. Genome Res. 2014;24:2022\u201332. https:\/\/doi.org\/10.1101\/gr.175141.114.","journal-title":"Genome Res"},{"key":"8628_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453\u20137. https:\/\/doi.org\/10.1038\/nmeth.3337.","journal-title":"Nat Methods"},{"key":"8628_CR30","doi-asserted-by":"publisher","unstructured":"Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14. https:\/\/doi.org\/10.1186\/1471-2105-14-7.","DOI":"10.1186\/1471-2105-14-7"},{"key":"8628_CR31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417\u201325. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004.","journal-title":"Cell Syst"},{"key":"8628_CR32","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1093\/bioinformatics\/btx378","volume":"33","author":"T Xu","year":"2017","unstructured":"Xu T, et al. CancerSubtypes: an R\/Bioconductor package for molecular cancer subtype identification, validation and visualization. Bioinformatics. 2017;33:3131\u20133. https:\/\/doi.org\/10.1093\/bioinformatics\/btx378.","journal-title":"Bioinformatics"},{"key":"8628_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y, et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol. 2024;42:293\u2013304. https:\/\/doi.org\/10.1038\/s41587-023-01767-y.","journal-title":"Nat Biotechnol"},{"key":"8628_CR34","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41586-019-0969-x","volume":"566","author":"J Cao","year":"2019","unstructured":"Cao J, et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature. 2019;566:496\u2013502. https:\/\/doi.org\/10.1038\/s41586-019-0969-x.","journal-title":"Nature"},{"key":"8628_CR35","doi-asserted-by":"publisher","unstructured":"Yu G. Thirteen years of clusterProfiler. Innov (Camb). 2024;5100722. https:\/\/doi.org\/10.1016\/j.xinn.2024.100722.","DOI":"10.1016\/j.xinn.2024.100722"},{"key":"8628_CR36","doi-asserted-by":"publisher","unstructured":"Seetharam D, et al. Activating antiviral immune responses potentiates immune checkpoint inhibition in glioblastoma models. J Clin Invest. 2025;135. https:\/\/doi.org\/10.1172\/JCI183745.","DOI":"10.1172\/JCI183745"},{"key":"8628_CR37","doi-asserted-by":"publisher","unstructured":"Meng S, et al. ZNF638 represses the transcription of HBV closed circular DNA involving HUSH complex-mediated histone modifications of epigenetic silencing. Cell Commun Signal. 2026;24. https:\/\/doi.org\/10.1186\/s12964-026-02726-1.","DOI":"10.1186\/s12964-026-02726-1"},{"key":"8628_CR38","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41419-020-03075-8","volume":"11","author":"W Ni","year":"2020","unstructured":"Ni W, et al. USP7 mediates pathological hepatic de novo lipogenesis through promoting stabilization and transcription of ZNF638. Cell Death Dis. 2020;11:843. https:\/\/doi.org\/10.1038\/s41419-020-03075-8.","journal-title":"Cell Death Dis"},{"key":"8628_CR39","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.gpb.2021.08.001","volume":"19","author":"T Chen","year":"2021","unstructured":"Chen T, et al. The Genome Sequence Archive Family: Toward Explosive Data Growth and Diverse Data Types. Genomics Proteom Bioinf. 2021;19:578\u201383. https:\/\/doi.org\/10.1016\/j.gpb.2021.08.001.","journal-title":"Genomics Proteom Bioinf"},{"key":"8628_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab951","author":"C-N Members","year":"2022","unstructured":"Members C-N, Partners. Database resources of the National genomics data center, China National center for bioinformation in 2022. Nucleic Acids Res. 2022;50:D27\u201338. https:\/\/doi.org\/10.1093\/nar\/gkab951.\u00a0"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08628-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08628-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08628-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:19:39Z","timestamp":1791418779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08628-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8628"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08628-7","relation":{"references":[{"id-type":"doi","id":"10.1093\/nar\/gkab951IF:","asserted-by":"subject"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This cohort study was registered (Date of Registration: 2022-10-01; Registration number: ChiCTR2200064248) and approved by the Ethics Committee of Peking University First Hospital (ethical number: 2022SR338) and conducted in accordance with relevant guidelines. Informed consent was obtained from all participants or their families.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that there is no conflict of interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1264"}}